PAD Special Edition: Intro to Paxlovid™ (nirmatrelvir/ritonavir)
|Personalized education in 30-60 minutes via in-person visit or web conferencing (e.g., Zoom or WebEx) at a time that is convenient for you.|
Note: This topic has not been accredited for Mainpro+ credits due to a need to develop the educational session urgently.
During each academic detailing session, participants will have the opportunity to:
- Discuss an overview of nirmatrelvir/ritonavir including:
- EPIC-HR trial
- eligibility criteria
- Review clinical considerations which support treatment decisions including:
- drug-drug interactions
- dosing (usual and renal)
When: Until June 2022
Where: Virtual academic detailing session
How: Email PAD@gov.bc.ca to schedule a time for your group
For more information about the PAD service, visit PAD Frequently Asked Questions.